Latest Genomic Valley Biotech stock price
Genomic Valley Biotech P/E Ratio
GVBL • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
76.24
High Valuation
Very High - High growth expectations or significantly overvalued
Current Valuation Metrics
P/E Ratio
76.24
Current Price
₹25.69
EPS (TTM)
₹1.17
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
53.23
Sector Median
30.38
Sector Rank
#11 of 131
Sector Percentile
8.4%
Key P/E Ratio Insights for Genomic Valley Biotech
- Stock appears overvalued with PE of 76.24, suggesting caution for new investments
- Trading at premium to sector average PE of 53.23
View the GVBL equity price for detailed stock performance.
Related Pages for Genomic Valley Biotech
Additional stock information and data for GVBL
Sector P/E Ratio Comparison
Comparing Genomic Valley Biotech with other companies in Healthcare sector
Sector Average
53.23
Sector Median
30.38
Lowest P/E
1.5
Highest P/E
628.04
Companies
131
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 1.5 | ₹51 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 3.18 | ₹733 | Low |
| Murae Organisor | MURAE | 3.86 | ₹55 | Low |
| Fermenta Biotech | FERMENTA | 9.01 | ₹1,010 | Low |
| Zenith Drugs | ZENITHDRUG | 9.06 | ₹84 | Low |
| Galaxy Medicare | GML | 9.5 | ₹32 | Low |
| Balaxi Pharmaceuticals | BALAXI | 10.06 | ₹139 | Low |
| Natco Pharma | NATCOPHARM | 10.8 | ₹17,006 | Low |
| Vasundhara Rasayans | VRL | 11.3 | ₹51 | Low |
| Mohini Health & Hygiene | MHHL | 11.84 | ₹69 | Low |